logo
episode-header-image
Nov 2025
25m 50s

The end of dieting

Vox
About this episode
The Trump administration is making GLP-1s more affordable. This class of drugs seems to have forever changed the game on diet and exercise for Americans. This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King. A pharmacist holds a box of O ... Show More
Up next
Today
Nevada's Trump slump
Nevada is in many ways “ground zero” for this year’s midterms. The state swung to the right in 2024 and voted for Donald Trump. Now, many voters there are grappling with buyer’s remorse. This show was edited by Kasia Broussalian, fact checked by Esther Gim, mixed by Shannon Mahon ... Show More
31m 19s
Yesterday
Life in the rage economy
The consumer experience is getting worse even as everything is getting more expensive. AI agents could make things better... or much, much worse. This episode was produced by Ariana Aspuru, edited by Jolie Myers, fact-checked by Gabriel Dunatov, engineered by David Tatasciore and ... Show More
25m 54s
Oct 29
Texas Talarico freakout
Texas hasn't elected a Democrat for Senate since 1988. James Talarico has a shot, but Republicans have launched a full culture war to try to prevent it. This episode was produced by Peter Balonon-Rosen, edited by Jolie Myers, fact-checked by Gabriel Dunatov, engineered by Bridger ... Show More
25m 58s
Recommended Episodes
Sep 2023
After Ozempic
Ozempic and other drugs like it are being heralded as game changers for weight loss. Radio Atlantic host Hanna Rosin talks to Atlantic staff writer Olga Khazan about what it means that this medical intervention has arrived at a time when our society seems to be easing away from f ... Show More
24m 15s
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Oct 2024
Hot shot: the wider promise of weight-loss jabs
<p>First they treated diabetes. Then obesity. Now <a href="https://www.economist.com/leaders/2024/10/24/its-not-just-obesity-drugs-like-ozempic-will-change-the-world?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.t ... Show More
23m 58s
Sep 2023
The Ozempic Era of Weight Loss
<p>Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.</p><p>Dani Blum, a reporter for The Times, tells the st ... Show More
37m 52s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Dec 2024
How Ozempic Transformed the Way We Look at Obesity
Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity.  Learn more about your ad choices. ... Show More
23m 47s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s